Ears, eyes, teeth — three senses that decline with age in ways you can't avoid, and almost everyone eventually needs something to help. What makes it interesting as a business is that most people pay for it themselves, because insurance and the state often don't cover it — creating markets with strong pricing power, few players, and constant repeat purchases. The trade-off: the risk is tied straight to the consumer's wallet, and new tech waves like AirPods are starting to shake the hearing-aid market.
Apple unveils Apple Watch Series 12 and Ultra 4 with new health features
Apple has announced its most advanced health and fitness experience yet, introducing the Apple Watch Series 12 and Apple Watch Ultra 4 with a new Health Sensing System that delivers the most accurate heart rate sensing in a wearable, along with a redesigned Health app powered by Apple Intelligence. The new watches measure heart rate every five seconds and HRV as often as every five minutes, 24 times more frequently, and introduce a readiness score from 0 to 10 with recommendations like Recover or Go For It. The redesigned Health app, coming later this year with iOS 27, adds an Insights tab and a Longevity tab featuring Health Age, which compares users' metrics to their chronological age. Users can also schedule and purchase lab tests covering over 50 biomarkers for $119 at approximately 2,000 Quest Diagnostics locations in the U.S., and new movement assessments use the iPhone camera and Apple Watch for at-home evaluations. The watches also support perimenopause and menopause tracking, and watchOS 27 will be available starting September 14 for Apple Watch Series 9 or later, Apple Watch SE 3, and Apple Watch Ultra 2 or later.
Taiwan Faces Demographic Crisis, Population Expected to Drop 48% to 12.15 Million by 2075
Bloomberg reports that Taiwan's population may decline to about 12.15 million by 2075, a drop of roughly 48% from 2026 levels, amid a continued decrease in births and young population, while the number of elderly rises significantly, posing long-term challenges to the labor market, economy, and defense capabilities. Estimates from Taiwan's National Development Council (NDC), based on household registration data, indicate that the working-age population will shrink by nearly two-thirds over the next 50 years. By 2075, the population aged 0-14 will be only 585,000, the working-age population (15-64) will be about 5.13 million, and those aged 65 and above will reach 6.43 million, meaning the elderly will outnumber the working-age population and account for more than half of the total population. These figures reflect risks after the population peaked at 23.6 million in 2019, and could also affect Taiwan's security, as the military still relies partly on conscription amid threats from China.
Medicare Advantage Plans Cut Grocery Cards and Dental Perks for 2026
Medicare Advantage plans are reducing supplemental benefits such as grocery cards and dental allowances for the 2026 plan year, even as many maintain $0 premiums. The overall MA market contracted by 9% to 3,373 individual plans, and 13% of individual MA-PD enrollees faced plan terminations, double the prior year's rate. While dental, vision, and hearing access remained broadly stable, fewer enrollees had plans offering over-the-counter benefits, meals, transportation, and in-home support. Insurers cite rising medical costs and payment pressure, with MedPAC estimating average rebates of nearly $2,400 per enrollee for individual plans in 2026. Beneficiaries whose plans are terminated generally receive guaranteed-issue rights for Medigap, but those in plans that cut benefits do not, and returning to Original Medicare outside the Medigap open-enrollment window can leave retirees with uncapped 20% coinsurance if insurers deny or price out coverage.
CHMP recommends EU approval of Roche's Susvimo for neovascular age-related macular degeneration
The European Medicines Agency's Committee for Medicinal Products for Human Use has recommended approval of Roche's Susvimo for the treatment of neovascular age-related macular degeneration. Susvimo is the first continuous delivery treatment that offers an alternative to standard-of-care eye injections, using the Contivue refillable implant to deliver a customized formulation of ranibizumab with as few as two treatments per year. The positive recommendation is based on data from the LADDER, Archway, and Portal studies showing Susvimo maintained vision equivalent to monthly intravitreal ranibizumab injections, with longer-term data supporting maintenance of vision up to seven years. A final decision from the European Commission is expected in the near future. Neovascular age-related macular degeneration affects 1.7 million people in the European Union and is a leading cause of blindness in people over 60.
Yuwell Medical Wrist Ambulatory Blood Pressure Monitor Receives Class II Medical Device Registration Certificate
Yuwell Medical announced that its wrist ambulatory blood pressure monitor has obtained a Class II medical device registration certificate issued by the Jiangsu Medical Products Administration. The product registration certificate number is Su Xie Zhu Zhun 20262071109, valid from July 24, 2026 to July 23, 2031, covering 12 models from WBA10 to WBA61. The product supports single blood pressure measurement, 24-hour ambulatory blood pressure measurement, and nighttime blood pressure monitoring, can record blood pressure data and display trends, and also features monitoring of health parameters such as heart rate, blood oxygen, stress, and sleep. It is used for measuring systolic pressure, diastolic pressure, and pulse rate in adults, with the values provided for clinical reference. The company stated that this is an important achievement of its digital and intelligent strategy centered on health management and wearable devices, which will enrich its wearable product matrix and improve its personal and family health management layout. It also cautioned that future sales are subject to uncertainties due to factors such as industry policies, market demand, and the competitive environment.
BDMS Launches Longevity Card Valued at 1 Million Baht, Targeting Luxury Wellness Market
BDMS Wellness Clinic, a subsidiary of Bangkok Dusit Medical Services Public Company Limited, or BDMS, has launched the Longevity Card, a personalized health care card valued at 1 million baht, to penetrate the luxury wellness market and elevate Thailand as a global health hub. Members will receive continuous care from a team of doctors and multidisciplinary professionals throughout one year, covering health monitoring programs, early-stage cancer and Alzheimer's risk screening, cellular and genetic analysis, as well as dental and skincare services. The card is available by invitation only with a limited number accepted each year, and is linked to benefits from a network of leading lifestyle and travel partners. Dr. Tanupol Virunhagarun, President of the BDMS Wellness Group Executive Committee, stated that the organization will continue to develop preventive health care technology to drive Thailand toward becoming a sustainable global health and wellness destination.
Dental Services Market to Reach USD 596.85 Billion by 2032
The global dental services market is projected to reach USD 425.56 billion in 2026 and grow at a compound annual growth rate of 5.65% to hit USD 596.85 billion by 2032, according to a new report from ResearchAndMarkets.com. The sector spans general dentistry, orthodontics, periodontics, prosthodontics, endodontics, oral surgery, pediatric dentistry, cosmetic dentistry, dental diagnostics, and maintenance services delivered through private practices, group practices, dental service organizations, public health systems, hospitals, and academic clinics. Demand is supported by the high global burden of oral diseases, aging populations, increasing awareness of preventive care, rising adoption of dental implants and clear aligners, and the growing link between oral health and systemic conditions such as diabetes, cardiovascular disease, respiratory infection risk, and adverse pregnancy outcomes. The World Health Organization estimates that oral diseases affect 3.5 billion people worldwide, making access to affordable, timely, and quality dental care a core public health priority. The report highlights transformative shifts including digital dentistry, teledentistry, artificial intelligence, minimally invasive procedures, and value-based care models, while noting persistent barriers such as uneven insurance coverage, workforce shortages in rural areas, and disparities in pediatric and geriatric oral healthcare access.
Medicare Lifetime Costs for Average Retiree Couple Projected at $688,996
A new report from HealthView Services projects that an average 65-year-old couple retiring in 2026 will pay $688,996 in Medicare premiums over their lifetimes. When additional costs such as hearing, vision, dental, copays, and deductibles are included, the total rises to $955,411. The report notes that healthcare cost inflation is expected to average 5.6% annually, roughly twice the rate of Social Security cost-of-living adjustments. The findings highlight the importance of planning for medical expenses in retirement, as Medicare does not cover all services and requires significant out-of-pocket spending.
Medicare Leaves Big Gaps; Dividend Growth Can Fund Quality-of-Life Costs
Original Medicare excludes dental, vision, hearing, and most wellness care, leaving retirees with out-of-pocket costs ranging from $3,000 to $15,000 or more per year. Covering $7,500 annually in dividends preserves capital, while spending a lump sum permanently depletes it. A 3.5% dividend portfolio growing payouts at 8% annually doubles its income in roughly nine years, outpacing a flat 10% yield over the long run. Retirees should estimate actual non-Medicare spending over the past two years and compare total returns of dividend-growth baskets against high-yield income funds.
SpaceX Stock Unlikely to Double Soon, but ADMA Biologics, EyePoint Pharmaceuticals, and Viking Therapeutics Could
SpaceX's stock is unlikely to double anytime soon due to its premium valuation and near-term insider selling risks, but three other stocks have realistic paths to doubling relatively quickly. ADMA Biologics is already profitable, with first-quarter net income of $407 million, up 22% year over year, and analysts' consensus 12-month price target is almost exactly double its current share price. EyePoint Pharmaceuticals expects top-line results from two late-stage studies of Duravyu for wet age-related macular degeneration any day now, targeting a combined global market opportunity of over $15 billion, and its consensus 12-month price target is 165% higher than the current share price. Viking Therapeutics is advancing its obesity candidate VK2735 in Phase 3 trials and plans to begin another late-stage study of oral VK2735 in the fourth quarter of 2026, with an average price target 146% above its current share price.
Audiology Devices Market to Reach USD 25.58 Billion by 2035
The global audiology devices market is projected to grow from USD 15.56 billion in 2025 to USD 25.58 billion by 2035, at a compound annual growth rate of 5.10 percent. North America held the largest share in 2025, with the U.S. market alone valued at approximately USD 5.24 billion and expected to reach USD 8.00 billion by 2035. Europe's market was estimated at USD 4.20 billion in 2025 and is forecast to reach USD 6.53 billion by 2035, while Asia Pacific is expected to register the fastest growth. Hearing aids accounted for about 48 percent of market revenue in 2025, and digital hearing technologies captured roughly 38 percent of revenue. The fastest-growing segments include assistive listening devices and remote audiology or tele-audiology solutions, driven by increasing adoption of AI-enabled hearing aids and virtual care platforms.
Concorde Career Colleges Launches 12 Additional Healthcare Programs
Concorde Career Colleges has launched 12 additional healthcare training programs across campuses in California, Florida, Missouri and Texas. The new offerings span five specialties: dental assistant, diagnostic medical sonography, pharmacy technician, radiologic technology and surgical technology. The expansion is part of parent company Universal Technical Institute's multi-year North Star strategy, which aims to launch 10 to 20 new programs annually at existing campuses through 2029. More than half of the spring launches are in radiologic technology and sonography, fields where the U.S. Bureau of Labor Statistics projects national employment growth of 5% and 13% respectively from 2024 to 2034. In the four states where the programs are being offered, projected growth for radiologic technologists ranges from 8% to 19% through 2032, while diagnostic medical sonography employment in California is expected to rise by 24%.